Effects of Steep Trendelenburg and Pneumoperitoneum on Cardiac Performance.
Conditions: Heart Failure, Systolic; Robotic Surgery; Esophageal Doppler Interventions: Device: Esophageal Doppler Sponsors: Karlstad Central Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
Prognostic Study of Visceral Fat and Heart Failure With Preserved Ejection Fraction
Conditions: Heart Failure With Preserved Ejection Fraction and Visceral Fat Sponsors: Chongqing Medical University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
Randomised Controlled Trial for Assessing the Effectiveness of an Inclusive Heart Failure Monitoring and TRACKing Solution in the UK.
Conditions: Heart Failure Interventions: Device: Heartfelt Device installed; Other: Standard care; Other: Questionnaires; Device: Heartfelt Device in pharmacy; Device: Heartfelt device alerting system Sponsors: Heartfelt Technologies Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
Technology Assisted Nudging to Increase Physical Activity Among Hospitalised Medical Patients
Conditions: COPD; Heart Failure; Parkinson Disease; Arthritis; Old Age; Cachexia; Stroke Sequelae Interventions: Behavioral: Digital nudging intervention target to change behavior Sponsors: Bispebjerg Hospital; AAL; Innovationsfonden Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
Real-world Study on Dapagliflozin Usage in Patients With Heart Failure (HF) in Germany
Conditions: Heart Diseases; Cardiovascular Diseases; Heart Failure Sponsors: AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
Screening for Heart Failure Using a Multimodal Wearable Device
Conditions: Heart Failure Interventions: Device: Watch HOP Sponsors: McGill University Health Centre/Research Institute of the McGill University Health Centre; HOP-Child Technologies Inc Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
Paced Heart Rate Acceleration for Cardiac Conditioning
Conditions: Heart Failure, Systolic Interventions: Device: Exercise-similar cardiac pacing; Device: Sham cardiac pacing Sponsors: Denice Hodgson-Zingman, MD; The Cleveland Clinic; National Institutes of Health (NIH); National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials
Efficacy of AI EF Screening by Using Smartphone Application Recorded PLAX View Cardiac Ultrasound Video Clips
Conditions: Heart Failure; Heart Failure With Reduced Ejection Fraction; Cardiac Failure; Echocardiography; Artificial Intelligence Interventions: Other: Easy EF Sponsors: Rayong Hospital; Chulalongkorn University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Mechanisms of Pulmonary Vascular Dysfunction in Heart Failure
Conditions: Heart Failure; Pulmonary Hypertension; Pulmonary Vascular Resistance Abnormality Interventions: Diagnostic Test: non-contrast chest CT; Diagnostic Test: spirometry with diffusing lung capacity for carbon monoxide (DLCO) analysis; Diagnostic Test: Omics analysis of blood plasma obtained from pulmonary artery or peripheral blood; Diagnostic Test: supine bike exercise during right heart catheterisation; Diagnostic Test: Lung ventilation/perfusion SPECT Sponsors: Institute for Clinical and Experimental Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
NIVIA-Hemodynamics
Conditions: Cardiogenic Shock; Heart Failure; Shock; Hemodynamic Instability Interventions: Diagnostic Test: Echocardiography and lung ultrasound Sponsors: University Health Network, Toronto Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System Pacing
Conditions: Arrhythmias, Cardiac; Atrioventricular Block; Reduced Systolic Function; Atrial Fibrillation; Bradyarrhythmia; Ventricular Tachycardia; Ventricular Dysfunction; Ventricular Fibrillation; Ventricular Arrythmia; Atrioventricular Nodal Disease; Atrioventricular Conduction Defects; Atrioventricular Block Complete; Atrioventricular Block Incomplete; Atrioventricular Junctional Rhythm; Bundle-Branch Block; Left Bundle-Branch Block; Heart Failure, Systolic; Block;Atrioventricular; Block; Arrhythmic; Block; Mobitz; Block, Heart; Block, Fascicular; Block Branch Bundle Left; Heart Failure ，Congestive; Heart Arrhythmia ...
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
Pulmonary Arteyr Denervation for Pulmonary Hypertension Secondary to Heart Failure With Reduced LVEF
Conditions: Isolated Pulmonary Hypertension From Heart Failure With Reduced Left Ventricular Ejection Fraction Interventions: Device: Pulmonary artery denervation (PADN) Sponsors: Nanjing First Hospital, Nanjing Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials
Pulmonary Artery Denervation for Treatment of Patients With Pulmonary Hypertension Secondary to Heart Failure With Reduced Ejection Fraction: a Safety and Proof-of-principle Cohort Study
Conditions: To Analyze the Safety and Efficacy of PADN for Pulmonary Hypertension Secondary to HFrEF Interventions: Device: PADN Sponsors: Shaoliang Chen, MD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials
Effect of Vericiguat on Endpoint Events in Acute Coronary Syndrome( ACS ）Patients With Ejection Fraction < 45%
Conditions: Acute Coronary Syndrome; Heart Failure With Reduced Ejection Fraction Interventions: Drug: Vericiguat Sponsors: The First Affiliated Hospital with Nanjing Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
A cluster-randomized study to evaluate the effectiveness and cost-effectiveness of the Assessment of Burden of Chronic Conditions (ABCC) tool in South Tyrolean primary care for patients with COPD, asthma, type 2 diabetes, and heart failure: the ABCC South Tyrol study
This study aims to validate the German and Italian versions of the ABCC tool and evaluate its effectiveness and cost-effectiveness in the South Tyrolean Primary Care setting.MethodsThis is a cluster-randomized study involving approximately 400 patients with COPD, asthma, type 2 diabetes, and heart failure who received care from the South Tyrolean General Practices. Initially, the ABCC tool will be translated into German and Italian and validated. Subsequently, half of the participants will use the validated ABCC tool for patient-reported outcome measurement assessments, while the other half will receive usual care. The pri...
Source: Trials - March 20, 2024 Category: Research Source Type: clinical trials
